NAM logo
  • site map
  • contact
  • advanced search
  • Home
  • News
  • Treatment & Care
  • HIV Worldwide
  • Living with HIV
  • Preventing HIV
  • Organisations
  • HIV Basics
  • About Us
 
Treatment & Care
  • español
  • français
  • português
  • pусский
Treatment & Care
  • Introduction to HIV and AIDS
    • The immune system and HIV
      • Monitoring the immune system
        • Genetics and HIV treatment
          • Pharmacogenetics
          • Genes, genetics, and inheritance
          • Effect of genetic variation on HIV drug levels
          • Effect of genetic variation on side-effects of HIV drugs
        • Preventing HIV infection
          • Ways of attacking HIV
            • Starting HIV treatment
              • Changing HIV treatment
                • Drug resistance
                  • Side-effects
                    • Adherence
                      • Drug interactions and pharmacokinetics
                        • HIV treatment during pregnancy
                          • HIV treatment in children
                            • Treatment guidelines
                              • A to Z of medical tests
                                • A to Z of drugs
                                  • Symptoms and illnesses
                                    support our work today
                                    YOU ARE HERE
                                    • > Home
                                      • > Treatment & Care
                                        • > Treatment & Care

                                    Genetics and HIV treatment

                                    printer-friendly versionsend to a friendglossarycomment

                                    • Pharmacogenetics
                                    • Genes, genetics, and inheritance
                                    • Effect of genetic variation on HIV drug levels
                                    • Effect of genetic variation on side-effects of HIV drugs

                                    latest aidsmap news

                                    • High rate of death amongst patients with HIV diagnosed late
                                    • CD4 cell count increases sustained up to five years in developing-world treatment programmes
                                    • Raltegravir may have role in PEP if exposure involves drug-resistant HIV
                                    • Excellent outcomes from five years of antiretroviral use in Botswana
                                    • Study explores verbal and non-verbal communication in unprotected sex between men
                                    • IL-2 provides quick ‘AIDS rescue’, but effect does not always last
                                    • Once-a-day etravirine should work as first-line treatment
                                    • Second-line combinations fail twice as often as first-line ones in the first year
                                    • If you can't switch, better to stay on failing treatment than stop it, studies show
                                    • Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’
                                     
                                    • Contact NAM
                                    • Get Email Updates
                                    • Disclaimer
                                    • Copyright
                                    • Developed By NAM